Czech companies are interested in participating in projects in nuclear energy, gas and oil extraction, and are ready to ...

Findings from a preclinical study demonstrate that Omomyc—the only direct MYC inhibitor to have successfully completed a ...

A team at Cincinnati Children’s has found that infiltrating macrophages — immune cells typically known for clearing waste and ...

Results from a VHIO-led study show that MYC targeting by Omomyc induces tumor DNA damage in patient-derived preclinical ...

BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / In recent years, LIXTE (NASDAQ:LIXT) has been defined by LB-100, its first-in-class PP2A inhibitor with a mechanism that unlocks new therapeutic a ...

Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients ...

A practical path to align affordability, transparency, and competition ...

Dr. Stanley Lang reopens Mercy Family Health in DuBois, PA, offering wholistic family medicine through a direct-pay model.

Climate change is no longer a distant concern, it is the harsh reality Sri Lanka is forced to confront again and again.

For 70 years, irrational fear of low-level radiation blocked the path to an energy-rich future. We must get over it.

Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.